Connect your AI

McKesson MCK Change in receivables

Change in receivables at other companies

Eli LillyLLY

$1.75B+225%

Cardinal HealthCAH

$17M-85.1%

The Oncology Institute, Inc.TOI

$994K—

OmnicellOMCL

$33.3M+701%

Other financials

Income statement

Revenue$96.3B+6.0%

Gross profit$4.0B+11.1%

Operating income$2.2B+35.1%

Net income$1.7B+33.5%

EPS (diluted)$13.65+37.6%

Balance sheet

Cash & equivalents$4.0B-33.3%

Total debt$2.3B-74.2%

Total equity-$2.2B-4.7%

Total assets$82.3B+9.6%

Cash flow

Operating cash flow$3.4B-55.8%

CapEx$111.0M-34.3%

Free cash flow$3.3B-56.3%

Valuation

Market cap$88.46B+2.1%

Enterprise value$86.77B-8.5%

P/E18.6×-8.8×

P/S0.2×0.0×

Profitability

Gross margin3.6%-0.1pp

Operating margin1.5%+0.3pp

Net margin1.2%+0.3pp

FCF margin1.4%-0.1pp

Returns & leverage

Return on equity36%—

Debt / equity2×—

Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInReceivables.

The official record: McKesson’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about McKesson's change in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is McKesson's change in receivables?: McKesson (MCK) reported change in receivables of $207M in Q3 2025.
How has McKesson's change in receivables changed year-over-year?: McKesson's change in receivables decreased by 85.2% year-over-year, from $1.4B to $207M.
What does change in receivables mean?: Change in total receivables including trade and non-trade receivables.